10-Q: Solitron Devices Reports Q2 Loss Amid Sales Decline

Solitron Devices, Inc. reported a net loss of $234,000 for the three months ended August 31, 2025, and a $570,000 net loss for the six months, driven by decreased net sales and increased administrative expenses.

Summary

• Net sales for the three months ended August 31, 2025, increased 11% to $3,986,000 compared to $3,581,000 in the prior year period.
• Net sales for the six months ended August 31, 2025, decreased 11% to $6,686,000 compared to $7,548,000 in the prior year period.
• Gross profit for the three months increased to $835,000 (21% of net sales) from $738,000 (21% of net sales).
• Gross profit for the six months decreased to $1,225,000 (18% of net sales) from $2,413,000 (32% of net sales), primarily due to higher material costs.
• Operating loss for the three months was ($291,000) compared to operating income of $50,000 in the prior year.
• Operating loss for the six months was ($669,000) compared to operating income of $842,000 in the prior year.
• Net loss for the three months was ($234,000) or ($0.11) per share, compared to net income of $17,000 or $0.01 per share in the prior year.
• Net loss for the six months was ($570,000) or ($0.27) per share, compared to net income of $606,000 or $0.29 per share in the prior year.
• Selling, general, and administrative expenses increased due to $331,000 in stock awards and options to senior management and directors.
• Net bookings for the three months ended August 31, 2025, increased 147% to $4,324,000 versus $1,752,000 in the prior year period.
• Net bookings for the six months ended August 31, 2025, increased 88% to $7,121,000 versus $3,793,000 in the prior year period.
• Backlog as of August 31, 2025, increased 146% to $18,642,000 compared to $7,572,000 as of August 31, 2024.
• Cash and cash equivalents decreased to $2,850,000 as of August 31, 2025, from $4,099,000 as of February 28, 2025, primarily due to a $1,650,000 long-term investment purchase.
• Working capital decreased to $6,390,000 as of August 31, 2025, from $8,594,000 as of February 28, 2025.

Sentiment

Score: 4

Explanation: While the company reported net losses and a significant decline in six-month gross profit and sales, the substantial increase in net bookings and backlog provides a positive signal for future revenue. However, the identified material weakness in internal controls and the immediate impact of increased SG&A expenses on profitability are notable concerns.

Positives

• Net sales for the three months ended August 31, 2025, increased 11% to $3,986,000 compared to $3,581,000 in the prior year.
• Net bookings for the three months ended August 31, 2025, increased 147% to $4,324,000.
• Net bookings for the six months ended August 31, 2025, increased 88% to $7,121,000.
• Backlog as of August 31, 2025, increased 146% to $18,642,000 compared to $7,572,000 in the prior year, indicating strong future revenue potential.
• Interest income increased to $42,000 for both the three and six months ended August 31, 2025, due to a long-term investment.
• Realized gains on investments increased to $170,000 for the three months and $251,000 for the six months ended August 31, 2025.
• The company repurchased 3,850 shares of common stock for approximately $63,000 under its stock repurchase program.
• Net cash provided by operating activities was $777,000 for the six months ended August 31, 2025.

Negatives

• Net sales for the six months ended August 31, 2025, decreased 11% to $6,686,000 compared to $7,548,000 in the prior year.
• Gross profit for the six months ended August 31, 2025, decreased to $1,225,000 (18% of net sales) from $2,413,000 (32% of net sales) in the prior year, primarily due to higher material costs.
• Operating income shifted to a loss of ($291,000) for the three months and ($669,000) for the six months ended August 31, 2025, compared to income in the prior year periods.
• Net loss for the three months ended August 31, 2025, was ($234,000) or ($0.11) per share, compared to net income of $17,000 or $0.01 per share in the prior year.
• Net loss for the six months ended August 31, 2025, was ($570,000) or ($0.27) per share, compared to net income of $606,000 or $0.29 per share in the prior year.
• Selling, general, and administrative expenses increased significantly due to $331,000 in stock awards and options to senior management and directors.
• Unrealized losses on investments for the three months were ($198,000) and for the six months were ($325,000).
• Cash and cash equivalents decreased by $1,249,000 for the six months ended August 31, 2025, primarily due to a $1,650,000 long-term investment purchase.
• Working capital decreased by $2,204,000 to $6,390,000 from $8,594,000.
• The company identified a material weakness in internal control over financial reporting in its prior annual report, and there was insufficient evidence to test the operating effectiveness of new controls as of August 31, 2025.

Risks

• Substantial customer concentration, where loss or reduction of business from significant customers could hurt revenues, profitability, and cash flow.
• Complex manufacturing processes may lower yields and reduce revenues.
• Inability to obtain qualified supplies of raw materials, parts, and finished components on a timely basis and at a cost-effective price.
• Increased international tariffs and threats of international tariffs.
• Dependence on government contracts, which are subject to termination, price renegotiations, and regulatory compliance.
• Inability to successfully execute acquisition strategy, potentially impacting growth and investment value.
• Continued inflationary pressures could lead to reduced margins and loss of future business.
• Changes in government policy, economic conditions, technology, or reductions in government spending could negatively impact results.
• Inventories may become obsolete, and other assets may be subject to risks.
• Environmental regulations could require significant costs.
• Highly competitive business environment could reduce gross profit margins.
• Changes in Defense related programs and priorities could reduce revenues and profitability.
• Operating results may decrease due to the decline of profitability in the semiconductor industry.
• Uncertainty of current economic conditions, domestically and globally, could continue to affect demand for products.
• Failure to achieve the intended effects of business strategy could adversely impact business, financial condition, and results of operations.
• Inability to introduce new products could result in decreased revenues and loss of market share; new technologies could also reduce demand.
• The nature of products exposes the company to potentially significant product liability risk.
• Dependence on the recruitment and retention of qualified personnel, with failure to attract and retain harming the business.
• Provisions in charter documents could make it more difficult to acquire the Company and may reduce the market price of stock.
• Natural disasters, like hurricanes, or other occurrences may affect markets, operations, and profitability.
• Failure to protect proprietary technologies or maintain the right to use certain technologies may negatively affect the ability to compete.
• Cannot guarantee sufficient capital resources for necessary investments in manufacturing technology and equipment.
• Substantial investments in property, plant, and equipment may become impaired.
• Risk due to the adverse financial condition of one or more customers.
• International operations expose the company to material risks, including under U.S. export laws.
• Security breaches and other disruptions could compromise information integrity and expose the company to liability.
• The price of common stock has fluctuated widely in the past and may fluctuate widely in the future.
• Cannot guarantee future cash dividend payments or share repurchases.
• Compliance with regulations regarding the use of "conflict minerals" could limit supply and increase the cost of certain metals.
• Failure to fully remediate and test controls related to the material weakness in internal control over financial reporting could adversely affect financial reporting accuracy and timing.

Future Outlook

The company expects its sole sources of liquidity over the next twelve months to be cash from operations and existing cash and cash equivalents, which are anticipated to be sufficient to fund approximately $250,000 in capital expenditures. To utilize current net operating loss carryforwards, the company may pursue acquisitions, additional product lines, and/or invest cash into common stocks or higher-yielding debt instruments. The company will also continue to consider additional share repurchases under its existing program.

Management Comments

• The increase in net sales for the three months was largely due to a lower backlog during fiscal year 2025 until the fourth quarter of the year and the associated delivery dates of those orders.
• The decrease in net sales for the six months was largely due to significantly lower sales during the first quarter of fiscal year 2026, which was the result of lower backlog during fiscal year 2025 and the delay in an expected order.
• Since we manufacture a wide variety of products with an average sales price ranging from a few dollars to several hundred dollars, such periodic variations in our volume of units shipped should not be regarded as a reliable indicator of our performance.
• We expect our sole sources of liquidity over the next twelve months to be cash from operations and cash and cash equivalents, if necessary.
• We anticipate that our capital expenditures required to sustain operations will be approximately $250,000 during the next twelve months and that our cash from operations and cash and cash equivalents, if necessary, will be sufficient to fund these needs for the next twelve months.
• Based on various factors, including the Company's desire to fully utilize its current net operating loss carryforwards, the Company may seek out acquisitions, additional product lines, and/or invest a portion of its cash into common stocks or higher yielding debt instruments.
• The Company will also continue to consider additional share repurchases under the Company's stock repurchase program subject to market conditions, corporate liquidity requirements and priorities and other factors as may be considered in the Company's sole discretion.

Industry Context

Solitron Devices operates in the specialized military and aerospace semiconductor components market, where most products are custom-made for U.S. Government contracts. This indicates a strong reliance on defense spending and government procurement cycles. The acquisition of Micro Engineering Inc. (MEI) suggests a strategic move to enhance capabilities in low to mid-volume electronic component design and manufacturing, potentially strengthening its niche or expanding its market reach. The reported higher cost of materials impacting gross profit reflects broader supply chain and inflationary pressures that could be affecting the semiconductor manufacturing industry. Customer concentration with major defense contractors (RTX/Raytheon, L3Harris) and a medical device company (ConMed Linvatec) highlights the company's dependence on a few key clients within its specialized sectors.

Management Changes

Corporate Governance

Legal Proceedings

• No known material current, pending, or threatened litigation as of August 31, 2025.

Related Party Transactions

• The company purchased die from ES Components, where Mr. Aubrey (a director) is a minority owner. Purchases totaled $8,000 for the three months and $58,000 for the six months ended August 31, 2025.
• For the three and six months ended August 31, 2024, the company purchased $57,000 and $90,000 of die, respectively, from ES Components.
• No sales were made to ES Components for the three and six months ended August 31, 2025, and August 31, 2024.

Stakeholder Impact

• Shareholders: Negative impact from net losses and decreased working capital, but potential positive from increased backlog and continued share repurchase program. Stock grants to management and directors could be seen as aligning interests.
• Employees: Stock grants to COO, President, CEO, CFO, and directors indicate management retention efforts and compensation.
• Customers: Strong backlog growth suggests continued demand for products, particularly from government contractors. Customer concentration remains a risk.
• Suppliers: Reliance on two major suppliers for a significant portion of production materials (47% for three months, 49% for six months) indicates potential supply chain risk.
• Creditors: Mortgage loans are in place, and the company expects sufficient liquidity for the next 12 months.

Next Steps

• Seek out acquisitions and/or additional product lines to utilize current net operating loss carryforwards.
• Invest a portion of cash into common stocks or higher yielding debt instruments.
• Continue to consider additional share repurchases under the Company's stock repurchase program.
• Remediate and test controls related to the material weakness in internal control over financial reporting.

Key Dates

Recommendation

While the company reported significant net losses and a decline in six-month sales and gross profit, the substantial increase in backlog and net bookings suggests a potential turnaround in future revenue. However, the identified material weakness in internal controls and the immediate impact of increased SG&A expenses on profitability warrant caution. Investors should hold to observe if the strong bookings translate into improved financial performance and if the internal control issues are effectively remediated. The high customer concentration and reliance on government contracts also present ongoing risks.

Keywords

Semiconductor components, Military, Aerospace, Solid-state devices, Power transistors, MOS, Hybrids, SEC filing, 10-Q, Solitron Devices, Micro Engineering Inc., Defense contracts, Manufacturing, Electronics, Financial reporting